Skip to main content

Table 3 Differences in use of lipid-lowering medication and meeting treatment targets for lipids by study

From: Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway

 KYHTromsø 7ORc (Tromsø 7/KYH) adjusted for age and sex (95% CI)ORc (Tromsø 7/KYH) adjusted for age, sex and education (95% CI)ORc (Tromsø 7/KYH) adjusted for age, sex, education and visiting a doctor in the past 12 months (95% CI)
n/total NAge and sex standardised %an/total NAge and sex standardised %a
MIUse of lipid-lowering medication91/23630.2270/37378.54.23 (2.94, 6.08)4.34 (2.97, 6.36)3.94 (2.67, 5.81)
Meets treatment target for lipid levelsb36/2365.141/33210.11.52 (0.80,2.88)1.33 (0.68, 2.58)1.29 (0.65, 2.53)
Meets treatment target for lipid levelsb
and on medication
27/9110.932/27010.90.87 (0.41, 1.84)0.77 (0.35, 1.67)0.75 (0.34, 1.64)
LDL-C ≥ 4 mmol/L48/23624.243/37310.00.44 (0.27, 0.69)0.44 (0.27, 0.72)0.47 (0.29, 0.77)
StrokeUse of lipid-lowering medication43/14322.3144/30738.92.31 (1.49, 3.58)2.20 (1.40, 3.47)2.08 (1.31, 3.28)
Meets treatment target for lipid levelsb25/14311.621/3075.80.61 (0.30, 1.28)0.62 (0.29, 1.33)0.60 (0.28, 1.28)
Meets treatment target for lipid levelsband on medication21/4341.917/1449.20.25 (0.10, 0.59)0.25 (0.10, 0.65)0.25 (0.10, 0.65)
LDL-C ≥ 4 mmol/L29/14329.748/30719.90.24 (0.15, 0.39)0.20 (0.12, 0.34)0.20 (0.12, 0.34)
DiabetesUse of lipid-lowering medication88/33622.6272/78630.71.78 (1.32, 2.40)1.71 (1.25, 2.34)1.66 (1.21, 2.28)
Meets treatment target for lipid levelsb118/33624.9191/78623.31.01 (0.74, 1.39)1.01 (0.73, 1.40)1.00 (0.72, 1.40)
Meets treatment target for lipid levelsb and on medication56/8833.3112/27242.70.83 (0.50, 1.37)0.85 (0.50, 1.44)0.86 (0.51, 1.45)
LDL-C ≥ 4 mmol/L64/33621.5182/78623.70.46 (0.28, 0.75)0.40 (0.23, 0.68)0.40 (0.23, 0.68)
  1. a Denominator is participants with included data on LDL-C (LDL-C missing for 9 participants in Know Your Heart; 10 participants Tromsø 7)
  2. bTreatment targets LDL-C < 1. 8 mmol/L for MI/stroke and diabetes with co-morbid stroke/ MI and < 2.6 mmol/L for diabetes with no co-morbid stroke/MI
  3. cExcluding those with missing data on education or visiting a doctor in the past 12 months